# US 2025/0002867 A1 · Method for producing pluripotent stem cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0002867 A1
- Document ID: US20250002867A1
- Status: Published application
- Kind: A1
- Application number: 18/695,303
- Filed: 2022-09-27
- Published: 2025-01-02
- Earliest claimed: 2021-09-28
- Assignees: CiRA Foundation
- Applicants: CiRA Foundation
- Inventors: Masayoshi TSUKAHARA; Yuko YAMAMOTO
- Web page: https://patentgrep.com/patent/US20250002867A1

## CPC

- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- C12M 1/00: Apparatus for enzymology or microbiology
- C12M 1/10: rotatably mounted
- C12M 23/02: {Form or structure of the vessel (large containers B65D88/00)}
- C12M 23/12: {Well or multiwell plates (C12M25/04 takes precedence)}
- C12M 23/26: {flexible (flexible containers for laboratory use B01L3/505)}
- C12M 27/16: {Vibrating; Shaking; Tilting}
- C12M 33/10: {by centrifugation (centrifuges in general B04B); Cyclones (cyclones in general B04C)}
- C12N 5/0657: {Cardiomyocytes; Heart cells}
- C12N 15/86: Viral vectors
- G06N 7/04: Physical realisation
- C12N 2501/125: Stem cell factor [SCF], c-kit ligand [KL]
- C12N 2501/145: Thrombopoietin [TPO]
- C12N 2501/22: Colony stimulating factors (G-CSF, GM-CSF)
- C12N 2501/2303: Interleukin-3 (IL-3)
- C12N 2501/2306: Interleukin-6 (IL-6)
- C12N 2501/26: Flt-3 ligand (CD135L, flk-2 ligand)
- C12N 2501/602: Sox-2
- C12N 2501/603: Oct-3/4
- C12N 2501/604: Klf-4
- C12N 2501/606: c-Myc
- C12N 2506/03: from non-embryonic pluripotent stem cells
- C12N 2506/11: from blood or immune system cells
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2760/18843: viral genome or elements thereof as genetic vector
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS

## Abstract

Provided is a method for producing pluripotent stem cells from somatic cells, comprising the steps of (1) seeding somatic cells in a container comprising at least one compartment configured to permit gathering two or more somatic cells; (2) bringing a reprogramming factor into contact with the somatic cells; and (3) culturing the somatic cells in contact with the reprogramming factor in a state where the two or more somatic cells are gathered in the compartment.

## Claims

### Claim 1

A method for producing pluripotent stem cells from somatic cells, comprising the steps of
(1) seeding somatic cells in a container having at least one compartment configured to permit gathering two or more somatic cells;
(2) bringing a reprogramming factor into contact with the somatic cells; and
(3) culturing the somatic cells in contact with the reprogramming factor in a state wherein the two or more somatic cells are gathered in the at least one compartment.

### Claim 2 (depends on 1)

The method according to claim 1, wherein
the compartment has a gathering portion with low cell adhesion configured to permit gathering two or more somatic cells; and
the method further comprises the step of gathering two or more somatic cells in the gathering portion.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the gathering step comprises at least one action selected from rotation, rocking and shaking of the container.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the container has a plurality of surfaces, and the container is rotated about a rotation axis that is parallel to or intersecting a first surface having the largest area of the plurality of surfaces.

### Claim 5 (depends on 4)

The method according to claim 4, wherein an angle of the rotation axis with respect to the first surface is a right angle.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the two or more somatic cells are gathered in a region closer to the rotation axis than the center of the container in a radial direction with respect to the rotation axis.

### Claim 7 (depends on 5)

The method according to claim 5, wherein the two or more somatic cells are gathered in a region more distant from the rotation axis than the center of the container in a radial direction with respect to the rotation axis.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the at least one compartment comprises
a recessed portion having an opening provided on a surface of the container and a bottom surface with low cell adhesion, and
wherein the recessed portion comprises
a gathering portion configured to permit gathering two or more somatic cells; and
a guide portion configured to guide the somatic cells flowing into the container to the gathering portion.

### Claim at position 9

9-16. (canceled)

### Claim 17 (depends on 8)

The method according to claim 8, wherein
the recessed portion is substantially shaped like a cone tapering from the opening to the bottom, and
the bottom surface constitutes the gathering portion, and the side surface of the recessed portion constitutes the guide portion.

### Claim 18

(canceled)

### Claim 19 (depends on 1)

The method according to claim 1, wherein the somatic cells are floating somatic cells.

### Claim at position 13

20-24. (canceled)

### Claim 25 (depends on 1)

The method according to claim 1, wherein the somatic cells are gathered at one point in the compartment in step (3).

### Claim 26 (depends on 25)

The method according to claim 25, wherein the somatic cells are seeded at 50 to 400 cells/compartment.

### Claim 27

(canceled)

### Claim 28 (depends on 1)

The method according to claim 1, wherein the somatic cells are gathered linearly in step (3).

### Claim 29 (depends on 28)

The method according to claim 28, wherein the somatic cells are seeded so that a theoretical value obtained by calculating the number of somatic cells accumulated on a cross section perpendicular to the linear portion is about 100 to 1,000.

### Claim 30

(canceled)

### Claim 31 (depends on 1)

The method according to claim 1, wherein in step (2) the reprogramming factor is brought into contact with the somatic cells by using a Sendai virus vector.

### Claim 32 (depends on 1)

The method according to claim 1, wherein the reprogramming factor is an RNA.

### Claim 33 (depends on 1)

The method according to claim 1, wherein the somatic cells are human somatic cells.

### Claim 34 (depends on 1)

The method according to claim 1, wherein step (2) is carried out after step (1).

### Claim at position 24

35-49. (canceled)

### Claim 50 (depends on 1)

A method for producing differentiated cells, comprising the steps of
providing pluripotent stem cells produced by the method according to claim 1; and
culturing the provided cells in a culture medium for inducing cell differentiation.

### Claim 51 (depends on 50)

The method according to claim 50, wherein the differentiated cells are cardiomyocytes.
